Delta variant establishes more than 6% of tested COVID-19 cases with virus variant in NYC: Health division Kumar Jeetendra | June 19, 2021 The Delta variant, first detected in India, constituted over 6 per cent of COVID-19 cases tested for virus variants in New York City, according to official data from the city’s health department. The New York City Health Department said in its recent update that out of the 105 NYC COVID-19 cases tested for variant viruses …
Researchers develop AI-based model to analyze cardiovascular illnesses and diabetes Kumar Jeetendra | August 14, 2021 Scientists from South Ural State University (SUSU), along with colleagues from France, Spain, and Egypt, have created a model that can be used to diagnose cardiovascular diseases and diabetes more effectively using artificial intelligence and Internet of Things technology. The Russian Ministry of Science and Higher Education supported this work. In an article published in …
Scientists find how Rift Valley fever virus enters cells Kumar Jeetendra | September 24, 2021 Rift Valley fever virus causes economically tragic hemorrhagic outbreaks in livestock, including cattle, goats, and sheep. The mosquito-borne infections can lead to the spread of infection to people who work with animals that are dying or dead often causing many human infections as well as many deaths. Rift Valley fever, for which there isn’t a …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
New technique to make a modest and rapid COVID-19 test dependent on isothermal amplification Kumar Jeetendra | December 30, 2021 Russian researchers have devised the method to make an affordable and quick COVID-19 test that relies on isothermal amplifying. According to their paper in Applied Biochemistry and Microbiology The using this method can allow researchers to create universal test methods for any COVID-19 variations. There are many options for devices that detect the presence of SARS-CoV-2 within human …
No diet suits all: Optimise nutrition as you age Kumar Jeetendra | March 8, 2022 As the world celebrates womanhood on March 8th, let’s pause to understand what healthy eating looks like for a woman. Literally. What should we be feeding our bodies so that we can enjoy good health throughout the changing stages of our lives? Whether you’re a student attending online classes or a corporate honcho working from …
Cipla Health’s “Naselin Shubhratri, Prajapati – The Guard” campaign bags “Silver” at Effie APAC Awards 2022 Kumar Jeetendra | September 9, 2022 Mumbai, 9 September: Naselin, one of the leading nasal decongestant brands by Cipla Health has swayed the stage away by winning the “Silver” at the Effie APAC Awards for its captivating yet appealing “Naselin Shubhratri, Prajapati – The Guard” campaign. Naselin becomes Cipla’s first ever brand to win a marketing award in the Asian Pacific region, which is one of the industry’s …
Nanomedicine for liver cancer developed by Amrita researchers gets US, Australia patent Kumar Jeetendra | September 13, 2022 Mumbai 13th Sept, 2022: Researchers from the School of Nanosciences & Molecular Medicine at Amrita Vishwa Vidyapeetham have won a patent in the US and Australia for a novel nanomedicine that holds great promise for early detection and treatment of liver cirrhosis and liver tumor. The invention is the outcome of a research project funded …
SMART and NTU Singapore develop a quick test kit to determine a person’s immunity against COVID-19 and its variants Kumar Jeetendra | September 25, 2022 A team of scientists from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University, Singapore (NTU Singapore) has developed a quick test kit that can tell if a person has immunity against COVID-19 and its variants, based on the antibodies detected in a blood sample. Different from …
Cipla launches CIPLAMED 2.0 – knowledge-sharing platform for Healthcare Practitioners (HCPS) Kumar Jeetendra | August 16, 2023 Mumbai, India; 16th August 2023: Cipla announced the launch of CiplaMed 2.0, an enhanced version of the industry-leading knowledge platform for the medical fraternity. In line with its digital transformation agenda, Cipla is pioneering an integrated omnichannel experience for healthcare professionals that seamlessly combines in-clinic interactions with digital engagement and access to medical information. This …
